Beclin-1 increases with obstructive sleep apnea severity - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Sleep Medicine Année : 2021

Beclin-1 increases with obstructive sleep apnea severity

Résumé

Obstructive sleep apnea is a common chronic disorder that leads to chronic intermittent hypoxia described as an important factor contributing to the pathogenesis of OSA-related comorbidities. Besides, recent data suggest that intermittent hypoxia can induce adaptative cardiovascular pathways inducing a relative resistance to ischemic insults. Adaptative pathways induced by hypoxia could implicate autophagic processes and Beclin-1, one of the first mammalian autophagy effectors. Thus, activation of autophagy could protect against cardiovascular events in patients with OSA and could be considered as biomarker of a better prognosis.
Fichier sous embargo
Fichier sous embargo
Date de visibilité indéterminée

Dates et versions

inserm-03534484 , version 1 (19-01-2022)

Identifiants

Citer

Frédéric Schlemmer, Maéva Zysman, Bruno Ribeiro Baptista, Etienne Audureau, Ala Covali Noroc, et al.. Beclin-1 increases with obstructive sleep apnea severity. Sleep Medicine, 2021, 81, pp.474-476. ⟨10.1016/j.sleep.2021.03.017⟩. ⟨inserm-03534484⟩

Collections

INSERM IMRB UPEC
30 Consultations
11 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More